FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171962227> ?p ?o ?g. }

• W2171962227 endingPage "117" @default.
• W2171962227 startingPage "114" @default.
• W2171962227 abstract "Background Anti-RNA polymerase III antibodies (anti-RNAP III) have been reported as potential immune markers of Systemic Sclerosis (SSc). Until now, their clinical use was disregarded because of technical difficulties to perform immunoprecipitation. Recently, ELISA kits became commercially available allowing an easy detection of anti-RNAP III. We intended to clarify the relevance of these antibodies in the diagnosis of SSc by ELISA detection. Methods The prevalence of anti-RNAP III was analyzed using two ELISA kits in 50 consecutive SSc patients from Marseilles in South of France. Controls included 66 patients with other systemic autoimmune diseases, 34 viral diseases and 50 healthy subjects. Positive results with at least one ELISA kit were controlled by immunoprecipitation which is the reference assay. Results In this study, positivity for anti-centromere and/or anti-topoisomerase I antibodies was observed in 84% of SSc patients. The prevalence of anti-RNAP III in SSc patients was 0% to 6% (3/50) depending on the ELISA kit and only 2% by immunoprecipitation. Concerning controls, two rheumatoid arthritis patients were positive using ELISA (6%), including one with immunoprecipitation confirmation. No anti-RNAP III was detected in systemic lupus erythematosus patients. Three blood donors and one viral disease control were positive using ELISA, but all were negative by immunoprecipitation. Conclusions Anti-RNAP III was rarely detected in a French population of SSc patients. Their prevalence was even lower than the one observed in rheumatoid arthritis controls. Therefore local immunologic profiles should be established before deciding a change in clinical practice for SSc immune screening." @default.
• W2171962227 created "2016-06-24" @default.
• W2171962227 creator A5002453054 @default.
• W2171962227 creator A5002481563 @default.
• W2171962227 creator A5010063238 @default.
• W2171962227 creator A5016648357 @default.
• W2171962227 creator A5017414227 @default.
• W2171962227 creator A5044759229 @default.
• W2171962227 creator A5056615047 @default.
• W2171962227 creator A5063428139 @default.
• W2171962227 creator A5068131579 @default.
• W2171962227 creator A5069603867 @default.
• W2171962227 creator A5085151012 @default.
• W2171962227 creator A5088345663 @default.
• W2171962227 creator A5091406923 @default.
• W2171962227 date "2010-04-01" @default.
• W2171962227 modified "2023-10-18" @default.
• W2171962227 title "Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population" @default.
• W2171962227 cites W1811963047 @default.
• W2171962227 cites W1917602840 @default.
• W2171962227 cites W1980442679 @default.
• W2171962227 cites W2001013737 @default.
• W2171962227 cites W2002027999 @default.
• W2171962227 cites W2007995865 @default.
• W2171962227 cites W2020283889 @default.
• W2171962227 cites W2028921539 @default.
• W2171962227 cites W2035705144 @default.
• W2171962227 cites W2045537500 @default.
• W2171962227 cites W2056293311 @default.
• W2171962227 cites W2078984463 @default.
• W2171962227 cites W2129498411 @default.
• W2171962227 cites W2133518113 @default.
• W2171962227 cites W2167816255 @default.
• W2171962227 cites W2168198817 @default.
• W2171962227 cites W2290529786 @default.
• W2171962227 cites W2299513640 @default.
• W2171962227 cites W2405078615 @default.
• W2171962227 cites W2413981303 @default.
• W2171962227 cites W2600375519 @default.
• W2171962227 cites W46650105 @default.
• W2171962227 doi "https://doi.org/10.1016/j.ejim.2010.01.004" @default.
• W2171962227 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20206882" @default.
• W2171962227 hasPublicationYear "2010" @default.
• W2171962227 type Work @default.
• W2171962227 sameAs 2171962227 @default.
• W2171962227 citedByCount "10" @default.
• W2171962227 countsByYear W21719622272012 @default.
• W2171962227 countsByYear W21719622272014 @default.
• W2171962227 countsByYear W21719622272015 @default.
• W2171962227 countsByYear W21719622272017 @default.
• W2171962227 countsByYear W21719622272019 @default.
• W2171962227 countsByYear W21719622272020 @default.
• W2171962227 crossrefType "journal-article" @default.
• W2171962227 hasAuthorship W2171962227A5002453054 @default.
• W2171962227 hasAuthorship W2171962227A5002481563 @default.
• W2171962227 hasAuthorship W2171962227A5010063238 @default.
• W2171962227 hasAuthorship W2171962227A5016648357 @default.
• W2171962227 hasAuthorship W2171962227A5017414227 @default.
• W2171962227 hasAuthorship W2171962227A5044759229 @default.
• W2171962227 hasAuthorship W2171962227A5056615047 @default.
• W2171962227 hasAuthorship W2171962227A5063428139 @default.
• W2171962227 hasAuthorship W2171962227A5068131579 @default.
• W2171962227 hasAuthorship W2171962227A5069603867 @default.
• W2171962227 hasAuthorship W2171962227A5085151012 @default.
• W2171962227 hasAuthorship W2171962227A5088345663 @default.
• W2171962227 hasAuthorship W2171962227A5091406923 @default.
• W2171962227 hasConcept C104317684 @default.
• W2171962227 hasConcept C126322002 @default.
• W2171962227 hasConcept C159047783 @default.
• W2171962227 hasConcept C159654299 @default.
• W2171962227 hasConcept C180032290 @default.
• W2171962227 hasConcept C203014093 @default.
• W2171962227 hasConcept C2776449523 @default.
• W2171962227 hasConcept C2777575956 @default.
• W2171962227 hasConcept C2779967694 @default.
• W2171962227 hasConcept C2908647359 @default.
• W2171962227 hasConcept C55493867 @default.
• W2171962227 hasConcept C63363279 @default.
• W2171962227 hasConcept C67705224 @default.
• W2171962227 hasConcept C70916841 @default.
• W2171962227 hasConcept C71829478 @default.
• W2171962227 hasConcept C71924100 @default.
• W2171962227 hasConcept C86803240 @default.
• W2171962227 hasConcept C99454951 @default.
• W2171962227 hasConceptScore W2171962227C104317684 @default.
• W2171962227 hasConceptScore W2171962227C126322002 @default.
• W2171962227 hasConceptScore W2171962227C159047783 @default.
• W2171962227 hasConceptScore W2171962227C159654299 @default.
• W2171962227 hasConceptScore W2171962227C180032290 @default.
• W2171962227 hasConceptScore W2171962227C203014093 @default.
• W2171962227 hasConceptScore W2171962227C2776449523 @default.
• W2171962227 hasConceptScore W2171962227C2777575956 @default.
• W2171962227 hasConceptScore W2171962227C2779967694 @default.
• W2171962227 hasConceptScore W2171962227C2908647359 @default.
• W2171962227 hasConceptScore W2171962227C55493867 @default.
• W2171962227 hasConceptScore W2171962227C63363279 @default.
• W2171962227 hasConceptScore W2171962227C67705224 @default.
• W2171962227 hasConceptScore W2171962227C70916841 @default.

• next